In recent years, titanium (IV) dioxide nanoparticles (TiO2NPs) have shown promising
potential in various biological applications such as antimicrobials, drug delivery …

Nanodrugs, which utilise nanomaterials in disease prevention and therapy, have attracted
considerable interest since their initial conceptualisation in the 1990s. Substantial efforts …

Deep-tissue optical imaging and photodynamic therapy (PDT) remain a big challenge for the
diagnosis and treatment of cancer. Chemiluminescence (CL) has emerged as a promising …

Atomistic details on the mechanism of targeting activity by biomedical nanodevices of
specific receptors are still scarce in the literature, where mostly ligand/receptor pairs are …

Active targeting strategies have been proposed to enhance the selective uptake of
nanoparticles (NPs) by diseased cells, and recent experimental findings have proven the …

Introduction Stimulus-responsive nanocarrier systems are promising in cancer treatment.
They improve drug stability and facilitate controlled drug release. However, single …

The emergence of liposomes has provided a breakthrough for the clinical use of highly toxic
chemotherapeutic drugs. However, the clinical effects of conventional drug-loaded …

Titanium oxide nanoparticles (TiO2 NPs) have been regarded as a legacy nanomaterial due
to their widespread usage across multiple fields. The TiO2 NPs have been and are still …

Nanoparticles'(NPs) permeation through cell membranes, whether it happens via passive or
active transport, is an essential initial step for their cellular internalization. The NPs' surface …

In recent decades, nanotechnology has significantly advanced drug delivery systems,
particularly in targeting subcellular organelles, thus opening new avenues for disease …